Alembic Pharma Gets 4 Observations From US FDA For Panelav Facility
Alembic Pharmaceuticals Ltd has received four observations from US Food and Drug Administration (FDA) for Panelav facility.The company stated that US FDA has conducted an inspection at it Panelav facility in Gujarat from 9-13 March, 2020"None of the observations are related to data integrity or repetitive in nature," the company added."The company will provide comprehensive corrective action report to address each observation. The company is committed to maintaining highest quality standards that meet US FDA standards," Alembic Pharma said in BSE filing.
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
